CAS: 2170729-29-8
Ref: AN-AG01V487
| 1mg | 67,00 € | |
| 5mg | 127,00 € | |
| 10mg | 166,00 € | |
| 25mg | 192,00 € | |
| 50mg | 232,00 € | |
| 100mg | 522,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
AT-007
CAS:2170729-29-8
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia …
Fórmula:
C17H10F3N3O3S2
Pureza:
99.36%
Forma y color:
Solid
Peso molecular:
425.4
Ref: TM-T10393
| 1mg | 79,00 € | |
| 5mg | 153,00 € | |
| 10mg | 233,00 € | |
| 25mg | 433,00 € | |
| 50mg | 635,00 € | |
| 100mg | 907,00 € | |
| 1ml*10 (DMSO) | 167,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
![2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid](https://static.cymitquimica.com/products/10/thumb/F546907.jpg)
2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid
CAS:2170729-29-8
Pureza:
98.0%
Peso molecular:
425.3999938964844
Ref: 10-F546907
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
AT-007
CAS:2170729-29-8
AT-007 is a research tool to be used as an activator, ligand, or receptor. It …
Fórmula:
C17H10F3N3O3S2
Pureza:
Min. 95%
Peso molecular:
425.4 g/mol
Ref: 3D-VLD72929
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
